S2-E29.1 – Previewing Digital ILC 2021 — Part 1 — Meeting Overview

Stephen Harrison and EASL Scientific Committee member Luca Valenti Preview Highlights of the Digital ILC 2021.

Luca and Stephen discuss what each of them consider highlights of this month’s Digital ILC meeting, focusing not only on presentation and poster topics but also a new meeting platform with improved connectivity. This brief discussion will help you get in the right frame of mind for planning your participation at EASL’s signature annual event.

TOPICS: cirrhosis, Diabetes, Diagnostic Tests, DrugTrial, EASL, Elastography, ELF, Fatty Liver, FIB-4, FibroScan, Fibrosis Level 3, Fibrosis Level 4, NAFLD, NASH, non-invasive liver testing, Obesity, Phase3, Digital ILC 2021, NAFLD Summit, virtual meeting rooms, networking, polygenic risk, combinatory biomarkers, Phase 2b, Pro-C3, renal disease, nutritionist, lifestyle interventions, patient outcomes, metabolic effects, glycemic controls, epidemiology, PMPLA3 gene, liver cancer

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Experience Nudge Learning! Interested in a new way of learning?